Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.
INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.
America’s vaccine system faces more than a crisis of public confidence. It faces a potential operational breakdown. Changing vaccine recommendations without accounting for manufacturing capacity, supply chains, distribution networks and patient access risks turning uncertainty into shortages, delays and declining vaccination rates.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
Modern food cooperatives, a legacy of 1960s counterculture, would seem well suited to an age of socially responsible consumption. Not-for-profit and owned by members, grocery co-ops promote healthy eating and sustainable agriculture, source from local producers and provide services to their local communities.
CHICAGO - New research could make air travel safer during the pandemic, as the number of people hitting the skies keeps climbing.
The world has marveled at the speed with which science took on and solved the task of creating effective vaccines for Covid-19. But another often-overlooked science — the engineering and management science of operations research — is now equally important for getting vaccines into the arms of Americans.
CATONSVILLE, MD, March 24, 2021 – COVID-19 has been shown to spread on airplanes by infected passengers, so minimizing the risk of secondary infections aboard aircraft may save lives. New research in the INFORMS journal Service Science uses two models to help solve the airplane seating assignment problem (ASAP). The models can lower the transmission risk of COVID-19 more so than the strategy of blocking the middle seats, given the same number of passengers.
The first Covid-19 vaccine candidate went into the arms of volunteers in Seattle in March 2020. It was an mRNA vaccine from Moderna. The mRNA candidate from BioNTech and Pfizer followed in April. By December 2020, these two had become the first vaccines to be approved by the US Food and Drug Administration (FDA). Hot on their heels are rivals based on adenovirus vectors from AstraZeneca and Johnson & Johnson, as well as Sputnik V from Russia.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine